2019 Friends 2019 Annual Meeting Panel 3 – Data Generation (and Review Considerations) for Use of a Companion Diagnostic for a Group of Oncology Therapeutic Products View PDF
2019 Friends 2019 Annual Meeting Panel 2 – Immuno-Oncology Combination Drug Development for Patients with Disease Progression After Initial anti-PD-(L)1 Therapy View PDF
2019 Friends 2019 Annual Meeting Panel 1 – Characterizing the Use of External Controls for Augmenting Randomized Control Arms and Confirming Benefit View PDF
2019 Friends 2019 Annual Meeting – Panel 1 Whitepaper: Characterizing the Use of External Controls for Augmenting Randomized Control Arms and Confirming Benefit View PDF
2019 8th Annual Blueprint for Breakthrough – Validating Real-World Endpoints for an Evolving Regulatory Landscape View PDF
2019 Opportunities for Combination Drug Development: Data Sources and Innovative Strategies to Assess Contribution of Components View PDF
